LLY vs UVV · P/E 39, rev $22.97B vs P/E 16, rev $2.89B
Eli Lilly and Company (LLY) versus Universal Corporation (UVV) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David A. Ricks.
Universal Corporation (UVV) is a tobacco company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported UVV revenue for 2026-03-31 was $2.89B. Net income was $32.6M. Revenue was down 1.3% from 2025-03-31 to 2026-03-31. UVV currently screens at market cap $1.46B and trailing P/E 15.6.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. UVV currently screens at market cap $1.46B and trailing P/E 15.6.
Not investment advice. Open the LLY and UVV stock pages for the full models.
Not investment advice.